BRIEF-Endocyte says ABX GmbH eligible for milestones of up to $160 mln under license agreement [Reuters]
ENDOCYTE (ECYT)
Last endocyte earnings: 11/7 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.endocyte.com/investor-relations
Company Research
Source: Reuters
BRIEF-Endocyte says ABX GmbH eligible for milestones of up to $160 mln under license agreement | Reuters Reuters Staff 1 Min Read Oct 2 (Reuters) - Endocyte Inc : * Endocyte Inc - ?ABX is eligible for regulatory and commercial milestones of up to $160 million, and tiered royalties beginning in mid-teens * Endocyte Inc - Intends to move quickly into phase 3 development of( 177)LU-PSMA-617, a radioligand therapeutic * Endocyte Inc - Phase 3 registration trial of( 177)LU-PSMA-617 planned to initiate in first half 2018 Source text for Eikon: Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2017 Reuters. All Rights Reserved. BRIEF-Endocyte says ABX GmbH eligible for milestones of up to $160 mln under license agreement Oct 2 (Reuters) - Endocyte Inc : * Endocyte Inc - ?ABX is eligible for regulatory and commercial milestones of up to $160 million, and tiered royalties beginning in mid-teens * Endocyte Inc
Show less
Read more
Impact Snapshot
Event Time:
ECYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ECYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ECYT alerts
High impacting ENDOCYTE news events
Weekly update
A roundup of the hottest topics